UCB SA engages in the research and development of biopharmaceuticals products. The company is headquartered in Anderlecht, Bruxelles-Capitale and currently employs 9,378 full-time employees. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.
Ucb SA a un dividende annuel de 0.79 par action, avec un rendement de 0.00%. Le dividende est payé annuellement et la dernière date d'ex-dividende était le Apr 28, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.79
Apr 28, 2025
Fréquence des paiements
Taux de distribution
Annuellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Apr 28, 2025
$0.7904
Apr 28, 2025
May 14, 2025
Apr 26, 2024
$0.728
Apr 29, 2024
May 15, 2024
May 1, 2023
$0.732
May 2, 2023
May 18, 2023
Apr 29, 2022
$0.6845
May 2, 2022
May 18, 2022
May 7, 2021
$0.7626
May 10, 2021
May 19, 2021
May 4, 2020
$0.6691
May 5, 2020
May 21, 2020
Graphiques des dividendes
UCBJY Dividendes
UCBJY Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Ucb SA et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Ucb SA ?
Quelle est la date ex-dividende pour UCBJY ?
À quelle fréquence Ucb SA verse-t-elle des dividendes ?